Ainos Inc. announces progress in clinical trials for AI Nose-powered Ainos Flora device detecting STIs, targeting Q3 design completion and Q4 clinical trials with NVIDIA CUDA.
Ainos Inc., a healthcare company focused on AI-powered point-of-care testing, announced critical progress in clinical trials for its AI Nose-powered Ainos Flora device. The device, which detects bacterial, fungal, and common STIs in women, now has 75 meaningful case results. Ainos Flora's next-gen version will advance with NVIDIA CUDA, with design completion targeted for Q3 and clinical trials for Q4.
June 14, 2024
4 Articles